New drug DW5524 tested in healthy people for first time
NCT ID NCT07349589
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial will test the safety and how the body handles a single dose of DW5524 in 48 healthy adults. Participants will be randomly assigned to receive either DW5524 or a related version, DW5524-A. The study aims to understand the drug's effects and how it moves through the body, but does not intend to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DW5524
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody tame the Body's allergic alarm system?
- Fingerprint sweat could replace oral swabs for drug testing
- Wearable tech puts hormone health to the test
- Can a better hazmat suit keep first responders safer and more effective?
- Home video tracking may expose the gap between clinic walking and real-world walking after stroke
- Avocado at breakfast: a secret weapon for blood sugar and fullness?